Nahdi Medical Co (SAU:4164) ROE % Adjusted to Book Value: 6.74% (As of Mar. 2026)


SAU:4164 Nahdi Medical Co SAU:4164
61 GF Score
Price ﷼91.90
GF Value ﷼140.70
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Nahdi Medical Co ROE % Adjusted to Book Value?

Nahdi Medical Co SAU:4164 -1.02% 61 ROE % Adjusted to Book Value is 6.74% as of Mar. 2026. GuruFocus rates SAU:4164 with a GF Score™ of 61/100 and a GF Value™ of ﷼140.70 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Nahdi Medical Co's ROE % for the quarter that ended in Mar. 2026 was 35.18%. Nahdi Medical Co's PB Ratio for the quarter that ended in Mar. 2026 was 5.22. Nahdi Medical Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 6.74%.

Nahdi Medical Co ROE % Adjusted to Book Value Related Terms

Nahdi Medical Co ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Nahdi Medical Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nahdi Medical Co ROE % Adjusted to Book Value Chart

Nahdi Medical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
0.00 4.76 5.25 5.50 6.93

Nahdi Medical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.64 6.02 4.03 5.95 6.74

Nahdi Medical Co ROE % Adjusted to Book Value Competitor Comparison

For the Pharmaceutical Retailers subindustry, Nahdi Medical Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nahdi Medical Co ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nahdi Medical Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Nahdi Medical Co's ROE % Adjusted to Book Value falls into.


SAU:4164
61GF Score
Nahdi Medical Co SAU:4164
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nahdi Medical Co ROE % Adjusted to Book Value Calculation

Nahdi Medical Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=31.17% / 4.50
=6.93%

Nahdi Medical Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=35.18% / 5.22
=6.74%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 6.74% mean?
Nahdi Medical Co (SAU:4164) has a ROE % Adjusted to Book Value of 6.74% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Nahdi Medical Co and its competitors.
Is Nahdi Medical Co's ROE % Adjusted to Book Value too high?
Nahdi Medical Co's current ROE % Adjusted to Book Value is 6.74%. Overall, Nahdi Medical Co has a GF Score™ of 61/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nahdi Medical Co's ROE % Adjusted to Book Value compare to competitors?
Nahdi Medical Co's ROE % Adjusted to Book Value of 6.74% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Nahdi Medical Co and its competitors. Nahdi Medical Co's current ROE % Adjusted to Book Value is 6.74%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nahdi Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Nahdi Medical Co (SAU:4164) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼140.70, compared to a current price of ﷼91.90 — trading 34.7% below its estimated fair value. The current ROE % Adjusted to Book Value is 6.74%. Nahdi Medical Co's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Nahdi Medical Co (SAU:4164), the current ROE % Adjusted to Book Value is 6.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nahdi Medical Co (SAU:4164) Overvalued in 2026?

Based on GuruFocus' analysis, Nahdi Medical Co stock appears to be undervalued. The current stock price of ﷼91.90 is trading 34.7% below its estimated GF Value™ of ﷼140.70. GuruFocus considers Nahdi Medical Co to be Significantly Undervalued.

Key valuation signals for SAU:4164:

  • ROE % Adjusted to Book Value: 6.74%
  • GF Value™: ﷼140.70 vs. price of ﷼91.90 (34.7% below fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the SAU:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nahdi Medical Co Business Description

Address Ibrg Alraghama, PO Box 17129, Jeddah, SAU, 21484
Nahdi Medical Co is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It has two operating segments: Front Shop and Pharma.
61GF Score

Get the complete analysis for SAU:4164

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼91.90
Price
﷼140.70
GF Value